Navigation Links
LenSar: New Laser Cure for Cataracts

NEW YORK, Nov. 5 /PRNewswire-FirstCall/ -- A new laser therapy that can potentially remove cataracts from people's eyes more efficiently and with greater precision was presented on October 24, 2009 at the American Academy of Ophthalmology (AAO) annual meeting. The technology, currently undergoing clinical trials outside the USA, was developed by LenSar, a start-up company which is in a head-to-head competition with two other players to be the first to commercialize the technology. LenSar plans to start treating patients if the FDA will consider the results of the remaining trials to be both safe and effective.

Although the new device will cost more than existing technologies, the speed of surgery may compensate for that by allowing more procedures to be performed in less time. The new LenSar laser cataract device is designed to be safer and easier to use, and it is believed that most cataract surgeons can learn to use it to perform surgeries with less complications. The laser will allow for the use of "premium" implants which set up bifocal vision as well as provide a better way to treat astigmatism.

Cataracts are presently treated with a devise known as a Phacoemulsifier, which uses ultrasound waves to break up the contents of the cataract and was nicknamed in the mid-seventies a "laser". This 35 years old device is generally very safe, however results are largely dependent on the individual surgeon's skills. LenSar suggests that their laser will make cataract surgery easier to perform, perhaps transforming average eye surgeons into surgeons equipped with safer and better technology, benefitting the three million patients who undergo cataract surgery annually in the U.S.

LenSar's CEO, Randy Frey, Ph.D., a well-acclaimed scientist known best for the Lasik laser he developed, formed LenSar in 2004 which has had about 100 operations performed outside of the U.S. with promising results. Although his cataract laser concept has spurred competing companies, Frey claims that he holds important patent applications which allow the company to focus on R&D and pay less attention to competitors. It is his belief that LenSar's patents will prevail and will have a legal claim on any such devices, regardless of their maker.

The real financial benefit for LenSar is not in the sale of the laser but in the "royalty-like" fee that is paid to the company each time the laser is used. Laser eye surgery devices by companies such as Alcon, Bausch and Lomb, and AMO have generated billions in revenue using this "click fee" strategy.


Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
2. American Laser Center Offers VelaShape Body Shaping and Cellulite Reduction Treatment
3. UltraShape(R) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Featured at American Society for Laser Medicine and Surgery Meeting
4. Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine"
5. DOT Therapy: Newest Breakthrough Technology in Laser Skin Resurfacing
6. Blue Light Destroys Antibiotic-Resistant Staph Infection - Results Reported in Photomedicine and Laser Surgery Journal
7. Laser Burn Injuries in One Eye Can Disrupt Protective Immune Privilege in Both Eyes, Study Finds
8. New Study Published in the Journal of Drugs in Dermatology Finds DOT Microablative CO2 Laser Optimum for Skin Rejuvenation
9. Studies Show Combination Laser Therapy Effective At Clearing Acne, Reducing Oil Production
10. Pivotal Clinical Data Published for the Only Laser Phototherapy Device Cleared by the FDA for Hair Growth
11. Published Study Shows VNUS ClosureFAST(TM) System Significantly Superior to Laser for Varicose Vein Treatment
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... Revolutionary technology includes multi-speaker listening ... industry leaders in advanced audiology and hearing aid technology, ... ™, the world,s first internet connected hearing aid that ...      (Photo: ) , ... ,world firsts,: , TwinLink™ - the first ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... ... , ... People across the U.S. are sharpening their pencils and honing their ... in which patients and their families pay tribute to a genetic counselor by nominating ... of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Frederick area economy by obtaining investment capital for emerging technology companies. ... years that have already resulted in more than a million dollars of capital ...
Breaking Medicine News(10 mins):